{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T23:32:49Z","timestamp":1790465569183,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.cmi.2019.04.006","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T11:42:22Z","timestamp":1555069342000},"page":"958-963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review"],"prefix":"10.1016","volume":"25","author":[{"given":"S.","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.K.","family":"Tosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.S.","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.04.006_bib1","series-title":"Antibiotic resistance threats in the United States","author":"US Department of Health and Human Services; Centers for Disease Control and Prevention","year":"2013"},{"key":"10.1016\/j.cmi.2019.04.006_bib2","series-title":"Antimicrobial resistance: global report on surveillance","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.cmi.2019.04.006_bib3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cmi.2014.12.025","article-title":"Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens","volume":"21","author":"Pogue","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.006_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1128\/AAC.01041-09","article-title":"Attributable hospital cost and length of stay associated with health care\u2013associated infections caused by antibiotic-resistant Gram-negative bacteria","volume":"54","author":"Mauldin","year":"2010","journal-title":"Antimicrob Agent Chemother"},{"key":"10.1016\/j.cmi.2019.04.006_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13756-018-0388-z","article-title":"Risk for subsequent infection and mortality after hospitalization among patients with multidrug-resistant Gram-negative bacteria colonization or infection","volume":"7","author":"Tseng","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.cmi.2019.04.006_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12879-015-1225-0","article-title":"Intestinal decolonization of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBL): a retrospective observational study in patients at risk for infection and a brief review of the literature","volume":"15","author":"Rieg","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.006_bib7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1473-3099(12)70322-5","article-title":"Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis","volume":"13","author":"Daneman","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.006_bib8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ajg.2013.59","article-title":"Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis","volume":"108","author":"Kassam","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cmi.2019.04.006_bib9","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/cid\/ciy721","article-title":"Low cure rates in controlled trials of fecal microbiota transplantation for recurrent Clostridium difficile infection: a systematic review and meta-analysis","volume":"68","author":"Tariq","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.006_bib10","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2018.198549","article-title":"Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematological malignancies carrying multidrug-resistance bacteria","author":"Battipaglia","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2019.04.006_bib11","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.cmi.2018.12.009","article-title":"A\u00a0five-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial","volume":"25","author":"Huttner","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.006_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.medmal.2018.11.002","article-title":"Fecal microbiota transplantation to eradicate vancomycin-resistant enterococci colonization in case of an outbreak","volume":"49","author":"Davido","year":"2019","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.cmi.2019.04.006_bib13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jhin.2018.02.018","article-title":"Clearance of carbapenem-resistant Enterobacteriaceae vs. vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study","volume":"99","author":"Dinh","year":"2018","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cmi.2019.04.006_bib14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13104-018-3293-x","article-title":"Fecal microbiota transplantation againstntestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae: a proof of principle study","volume":"11","author":"Singh","year":"2018","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.cmi.2019.04.006_bib15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/cid\/cix252","article-title":"Fecal microbiota transplantation in patients with blood disorders inhibits gut colonization with antibiotic-resistant bacteria: results of a prospective, single-center study","volume":"65","author":"Bilinski","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.006_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhin.2017.02.001","article-title":"Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage?","volume":"95","author":"Davido","year":"2017","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cmi.2019.04.006_bib17","first-page":"376","article-title":"Impact of faecal microbiota transplantation to eradicate vancomycin-resistant enterococci (VRE) colonization in humans","volume":"75","author":"Davido","year":"2017","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2019.04.006_bib18","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/bmt.2017.151","article-title":"Faecal microbiota transplant: a novel biological approach to extensively drug-resistant organism\u2013related non-relapse mortality","volume":"52","author":"Innes","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2019.04.006_bib19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.17235\/reed.2017.4425\/2016","article-title":"Fecal microbiota transplantation: is there a role in the eradication of carbapenem-resistant Klebsiella pneumoniae intestinal carriage?","volume":"109","author":"Ponte","year":"2017","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.cmi.2019.04.006_bib20","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/cid\/cix618","article-title":"Fecal microbiota transplantation for recurrent Clostridium difficile infection reduces recurrent urinary tract infection frequency","volume":"65","author":"Tariq","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.006_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00005-016-0387-9","article-title":"Fecal microbiota transplantation inhibits multidrug-resistant gut pathogens: preliminary report performed in an immunocompromised host","volume":"64","author":"Bilinski","year":"2016","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.cmi.2019.04.006_bib22","doi-asserted-by":"crossref","first-page":"ofw133","DOI":"10.1093\/ofid\/ofw133","article-title":"Clearance of vancomycin-resistant Enterococcus concomitant with administration of a microbiota-based drug targeted at recurrent Clostridium difficile infection","volume":"3","author":"Dubberke","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.006_bib23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.diagmicrobio.2016.09.004","article-title":"Gut eradication of VIM-1 producing ST9 Klebsiella oxytoca after fecal microbiota transplantation for diarrhea caused by a Clostridium difficile hypervirulent R027 strain","volume":"86","author":"Garcia-Fernandez","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.006_bib24","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1017\/ice.2016.229","article-title":"Can fecal microbiota transplantation (FMT) eradicate fecal colonization with vancomycin-resistant enterococci (VRE)?","volume":"37","author":"Sohn","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2019.04.006_bib25","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1128\/JCM.00820-15","article-title":"Fecal microbiota transplantation and successful resolution of multidrug-resistant-organism colonization","volume":"53","author":"Crum-Cianflone","year":"2015","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.04.006_bib26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5217\/ir.2015.13.1.80","article-title":"Refractory Clostridium difficile infection cured with fecal microbiota transplantation in vancomycin-resistant Enterococcus colonized patient","volume":"13","author":"Jang","year":"2015","journal-title":"Intest Res"},{"key":"10.1016\/j.cmi.2019.04.006_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jhin.2015.02.013","article-title":"Faecal microbiota transplantation for stool decolonization of OXA-48 carbapenemase\u2013producing Klebsiella pneumoniae","volume":"90","author":"Lagier","year":"2015","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cmi.2019.04.006_bib28","doi-asserted-by":"crossref","first-page":"ofv078","DOI":"10.1093\/ofid\/ofv078","article-title":"Loss of vancomycin-resistant Enterococcus fecal dominance in an organ transplant patient with Clostridium difficile colitis after fecal microbiota transplant","volume":"2","author":"Stripling","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.006_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12879-015-0973-1","article-title":"Fecal microbiota transplantation restores dysbiosis in patients with methicillin resistant Staphylococcus aureus enterocolitis","volume":"15","author":"Wei","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.006_bib30","doi-asserted-by":"crossref","first-page":"O977","DOI":"10.1111\/1469-0691.12683","article-title":"Donor feces infusion for eradication of extended spectrum beta-lactamase producing Escherichia coli in a patient with end stage renal disease","volume":"20","author":"Singh","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.006_bib31","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmi.2019.04.006_bib32","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/cid\/cix821","article-title":"Antimicrobial resistance gene acquisition and depletion following fecal microbiota transplantation for recurrent Clostridium difficile infection","volume":"66","author":"Leung","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.006_bib33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13756-018-0390-5","article-title":"Germs of thrones\u2014spontaneous decolonization of carbapenem-resistant Enterobacteriaceae (CRE) and vancomycin-resistant enterococci (VRE) in Western Europe: is this myth or reality?","volume":"7","author":"Davido","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.cmi.2019.04.006_bib34","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1093\/jac\/dkw221","article-title":"Natural history and decolonization strategies for ESBL\/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis","volume":"71","author":"Bar-Yoseph","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.04.006_bib35","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1017\/ice.2016.202","article-title":"A\u00a0novel risk factor associated with colonization by carbapenemase-producing Enterobacteriaceae: use of proton pump inhibitors in addition to antimicrobial treatment","volume":"37","author":"Cheng","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2019.04.006_bib36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/659762","article-title":"Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter","volume":"32","author":"Schechner","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2019.04.006_bib37","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/apt.14201","article-title":"Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection","volume":"46","author":"Quraishi","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cmi.2019.04.006_bib38","doi-asserted-by":"crossref","first-page":"S1081","DOI":"10.21037\/jtd.2018.04.18","article-title":"Microbiota replacement for Clostridium difficile by capsule is as effective as via colonoscopy","volume":"10","author":"Saha","year":"2018","journal-title":"J\u00a0Thorac Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19301582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19301582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:23:48Z","timestamp":1761117828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19301582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1198743X19301582"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.04.006","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}